Office of the Commissioner of Lobbying of Canada Office of the Commissioner of Lobbying of Canada

Language selection

Registry of Lobbyists

Advanced Registry Search Results

Search History (1)

Search Criteria

  1. Lobbyist name (consultant or in-house lobbyist): BELZILE, ANNE-SOPHIE OR;
  2. Responsible officer name: BELZILE, ANNE-SOPHIE
Share this search Create an alert
Start over
Modify criteria

Refine registrations results by

Status Type Subject matter Government institutions

Refine monthly communication reports results by

If you would like to view a summary of the last 12 months for a lobbying activity, use the 12-Month Lobbying Activity Search

Registration (40)
Results: 1-40 | Export
  1. Dairy Farmers of Canada / Les Producteurs laitiers du Canada
    Type: In-house Organization
    Responsible officer: Jacques Lefebvre, Chief Executive Officer
    Registration: 102 of 102 (2024-04-04 to present)
    Posted: 2024-05-01
    Subject matter details: 36
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  2. Dairy Farmers of Canada / Les Producteurs laitiers du Canada
    Type: In-house Organization
    Responsible officer: Jacques Lefebvre, Chief Executive Officer
    Registration: 101 of 102 (2023-05-01 to 2024-04-04)
    Posted: 2023-05-15
    Subject matter details: 36
    Government institutions: 24
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  3. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 98 of 115 (2022-09-07 to 2022-09-16)
    Posted: 2022-09-07
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  4. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 97 of 115 (2022-07-25 to 2022-09-07)
    Posted: 2022-07-26
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  5. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 96 of 115 (2022-06-08 to 2022-07-25)
    Posted: 2022-06-08
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  6. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 95 of 115 (2022-05-11 to 2022-06-08)
    Posted: 2022-05-11
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 11
  7. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 94 of 115 (2022-03-18 to 2022-05-11)
    Posted: 2022-04-13
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  8. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 93 of 115 (2021-12-14 to 2022-03-18)
    Posted: 2021-12-14
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  9. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 92 of 115 (2021-10-22 to 2021-12-14)
    Posted: 2021-10-22
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  10. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 91 of 115 (2021-10-04 to 2021-10-22)
    Posted: 2021-10-05
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  11. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 90 of 115 (2021-08-26 to 2021-10-04)
    Posted: 2021-08-26
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  12. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 89 of 115 (2021-07-13 to 2021-08-26)
    Posted: 2021-07-13
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  13. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 88 of 115 (2021-03-01 to 2021-07-13)
    Posted: 2021-03-01
    Subject matter details: 28
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  14. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 87 of 115 (2021-02-16 to 2021-03-01)
    Posted: 2021-02-16
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  15. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 86 of 115 (2021-01-04 to 2021-02-16)
    Posted: 2021-01-04
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  16. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 85 of 115 (2020-10-26 to 2021-01-04)
    Posted: 2020-10-26
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 12
  17. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 84 of 115 (2020-10-09 to 2020-10-26)
    Posted: 2020-10-09
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  18. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 83 of 115 (2020-09-03 to 2020-10-09)
    Posted: 2020-09-03
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  19. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 82 of 115 (2020-08-10 to 2020-09-03)
    Posted: 2020-08-10
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  20. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 81 of 115 (2020-05-25 to 2020-08-10)
    Posted: 2020-05-25
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 13
  21. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 80 of 115 (2020-03-10 to 2020-05-25)
    Posted: 2020-03-10
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 14
  22. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 79 of 115 (2020-01-08 to 2020-03-10)
    Posted: 2020-01-09
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  23. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 78 of 115 (2019-11-15 to 2020-01-08)
    Posted: 2019-11-15
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  24. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 77 of 115 (2019-09-11 to 2019-11-15)
    Posted: 2019-09-11
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  25. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 76 of 115 (2019-08-02 to 2019-09-11)
    Posted: 2019-08-02
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  26. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 74 of 115 (2019-07-11 to 2019-07-11)
    Posted: 2019-07-11
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  27. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 75 of 115 (2019-07-11 to 2019-08-02)
    Posted: 2019-07-11
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  28. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 73 of 115 (2019-02-12 to 2019-07-11)
    Posted: 2019-02-13
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  29. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 72 of 115 (2019-01-11 to 2019-02-12)
    Posted: 2019-01-11
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 16
  30. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 71 of 115 (2019-01-03 to 2019-01-11)
    Posted: 2019-01-04
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  31. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 70 of 115 (2018-10-15 to 2019-01-03)
    Posted: 2018-10-15
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 18
  32. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 69 of 115 (2018-08-02 to 2018-10-15)
    Posted: 2018-08-02
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 19
  33. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 68 of 115 (2018-07-20 to 2018-08-02)
    Posted: 2018-07-20
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 18
  34. Innovative Medicines Canada / Médicaments novateurs Canada
    Type: In-house Organization
    Responsible officer: Pamela Fralick, President
    Registration: 67 of 115 (2018-06-28 to 2018-07-20)
    Posted: 2018-07-03
    Subject matter details: 27
    Government institutions: 26
    Communication techniques: 3
    Government funding: No
    Employees who lobby: 17
  35. Mental Health Commission of Canada / Commission de la santé mentale du Canada
    Type: In-house Organization
    Responsible officer: Louise Bradley, President and CEO
    Registration: 26 of 26 (2018-01-23 to 2018-01-23)
    Posted: 2018-01-25
    Subject matter details: 2
    Government institutions: 13
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 5
  36. Mental Health Commission of Canada / Commission de la santé mentale du Canada
    Type: In-house Organization
    Responsible officer: Louise Bradley, President and CEO
    Registration: 25 of 26 (2017-08-03 to 2018-01-23)
    Posted: 2017-08-15
    Subject matter details: 3
    Government institutions: 13
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 5
  37. Mental Health Commission of Canada / Commission de la santé mentale du Canada
    Type: In-house Organization
    Responsible officer: Louise Bradley, President and CEO
    Registration: 24 of 26 (2016-10-11 to 2017-08-03)
    Posted: 2016-11-23
    Subject matter details: 3
    Government institutions: 13
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 10
  38. Mental Health Commission of Canada / Commission de la santé mentale du Canada
    Type: In-house Organization
    Responsible officer: Louise Bradley, President and CEO
    Registration: 23 of 26 (2016-08-30 to 2016-10-11)
    Posted: 2016-09-02
    Subject matter details: 3
    Government institutions: 13
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 6
  39. Mental Health Commission of Canada / Commission de la santé mentale du Canada
    Type: In-house Organization
    Responsible officer: Louise Bradley, President and CEO
    Registration: 22 of 26 (2016-07-19 to 2016-08-30)
    Posted: 2016-07-22
    Subject matter details: 3
    Government institutions: 13
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 7
  40. Mental Health Commission of Canada / Commission de la santé mentale du Canada
    Type: In-house Organization
    Responsible officer: Louise Bradley, President and CEO
    Registration: 21 of 26 (2016-03-07 to 2016-07-19)
    Posted: 2016-03-10
    Subject matter details: 4
    Government institutions: 11
    Communication techniques: 2
    Government funding: Yes
    Employees who lobby: 7
Date Modified: